N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide
C79H53ClF9N19O6S — CID 158514885
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide
N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide (PubChem CID 158514885) has the molecular formula C79H53ClF9N19O6S and a molecular weight of 1602.92 g/mol. Its IUPAC name is N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide |
|---|---|
| PubChem CID | 158514885 |
| Molecular Formula | C79H53ClF9N19O6S |
| Molecular Weight | 1602.92 g/mol |
| Exact Mass | 1601.37 |
| IUPAC Name | N-[4-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]pyridazine-3-carboxamide;N-[1-[(4-cyanophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[4-cyano-1-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-c]pyridin-3-yl]furan-3-carboxamide;N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-thiazole-3-carboxamide |
| SMILES | Cc1occc1C(=O)Nc1nn(Cc2ccc(C#N)cc2)c2ccccc12.N#Cc1cncc2c1c(NC(=O)c1ccoc1)nn2Cc1ccc(C(F)(F)F)cc1.O=C(Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2ccccc12)c1ccsn1.O=C(Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2cncc(Cl)c12)c1cccnn1 |
| InChI | InChI=1S/C21H16N4O2.C20H12F3N5O2.C19H12ClF3N6O.C19H13F3N4OS/c1-14-17(10-11-27-14)21(26)23-20-18-4-2-3-5-19(18)25(24-20)13-16-8-6-15(12-22)7-9-16;21-20(22,23)15-3-1-12(2-4-15)10-28-16-9-25-8-14(7-24)17(16)18(27-28)26-19(29)13-5-6-30-11-13;20-13-8-24-9-15-16(13)17(26-18(30)14-2-1-7-25-27-14)28-29(15)10-11-3-5-12(6-4-11)19(21,22)23;20-19(21,22)13-7-5-12(6-8-13)11-26-16-4-2-1-3-14(16)17(24-26)23-18(27)15-9-10-28-25-15/h2-11H,13H2,1H3,(H,23,24,26);1-6,8-9,11H,10H2,(H,26,27,29);1-9H,10H2,(H,26,28,30);1-10H,11H2,(H,23,24,27) |
| InChIKey | HLMVKRBGHYNIFZ-UHFFFAOYSA-N |
| XLogP | 17.33 |
| TPSA | 325.99 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 115 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1602.92 |
| LogP ≤ 5 | 17.33 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158514885 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.